Forefront Analytics’s HCA Healthcare HCA Stock Holding History

Forefront Analytics’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17	Closed	-$1.53K	–	91
2020 Q1	$1.53K	Buy	+17	New	+$2.2K	﹤0.01%	111

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Forefront Analytics's HCA Position: Q2 2020 in Review

Forefront Analytics sold out of HCA Healthcare (HCA) in Q2 2020, closing a stake of 17 shares — an estimated $1.53K sold.

Forefront Analytics first reported a position in HCA in Q1 2020 and held it in 1 quarter. The position peaked at $1.53K in Q1 2020. 685 funds tracked by Wall St. Rank hold HCA as of Q2 2020.

Forefront Analytics reported no remaining HCA Healthcare position as of Q2 2020 after selling out during the quarter.
Forefront Analytics sold 17 HCA Healthcare shares in Q2 2020, an estimated $1.53K.
Forefront Analytics first reported a position in HCA Healthcare in Q1 2020 and held it in 1 quarter.
Forefront Analytics's HCA Healthcare position peaked at $1.53K in Q1 2020.
685 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2020.

Based on Forefront Analytics's 13F filing for Q2 2020, filed 10 Aug 2020.